ECS10 CORRECTING PRESBYOPIA IN YOUNG PATIENTS WITH THE PHAKIC ARTIPLUS LENS J. Guëll1,* 1IMO Instituto de Microcirugía Ocular, Barcelona, Spain Ophtec is a family owned business that develops ingenious lenses, different from the usual market concepts. The Artiplus phakic IOL is such an ingenuous lens. It is an iris fixated lens that makes use of […]
ECS11 OLLEYES VISUALL: A NOVEL VIRTUAL REALITY PLATFORM IN GLAUCOMA CARE J. Fernandez1,* 1Olleyes, Summit, United States Olleyes, is a medical device company developing mobile and home-based diagnostic products for eye disorders. At Olleyes, we make eye care more productive and personalized with VisuALL VRP— a portable visual care testing platform, which currently includes […]
ECS09 VALENS: INNOVATIVE POSTOPERATIVE ADJUSTABLE IOL. VALENS IS AN IOL CRADLE SYSTEM WITH A POSTOPERATIVE, REPEATABLE, ADJUSTABLE LENS POSITION, WHICH ENABLES NON-INVASIVE REFRACTIVE OPTIMIZATION AFTER LENS IMPLANTATION AND WOUND HEALING. N. Shimoni1,* 1EyeMed Technologies Ltd., Or Yehuda, Israel Technology: VaLens is an intra-ocular lens cradle system which enables the physician to precisely adjust the power […]
ECS08 EPI SMART, TRUE EPI-ON CORNEAL CROSS-LINKING FOR KERATOCONUS M. Webb1,* 1CXL Ophthalmics, INC, Burlington, United States CXL Ophthalmics (CXLO) is developing innovative treatments for corneal diseases with the goal of saving and improving vision for millions of patients around the world. EpiSmart™ is a transformative cross-linking system targeting keratoconus, a common type of corneal […]
ECS01 MULTIFOCAL IOLS SEE-THROUGH SIMULATOR – ENHANCING THE PATIENT EXPERIENCE WITH A TAILORED IOL SELECTION S. Marcos1,2,* 12EyesVision, Madrid, Spain, 2University of Rochester, Rochester, United States Presbyopia affects 100% of the population above 45 years old and cataracts 45% of the population above 75. The surgical correction for these conditions – affecting 1.8 billion people […]
ECS05 DRUG DELIVERY CONTACT LENS TECHNOLOGY TO TREAT EYE DISEASE C. Adams1,* 1Glint Pharmaceuticals, Cambridge, United States Glint has developed a novel, patented approach for extended drug delivery by the incorporation of vitamin E (α tocopherol) in commercial silicon hydrogel contact lenses. The use of commercial contact lenses that are already approved by the FDA, […]
ECS04B ATIA VISION AND THE OMNIVU MODULAR, SHAPE-CHANGING INTRAOCULAR LENS D. Stephenson 1,2,* 1Stephenson Eye Associates, Venice, 2Atia Vision, Campbell, United States Atia Vision, Inc., a Shifamed portfolio company, is committed to improving the visual outcomes of patients undergoing cataract surgery through the development of an intraocular lens that restores the full range of […]
LensGen, a clinical stage opthalmic device company based in Irvine, California has developed a distruptive shape changing fluid intraocular lens (IOL) for treating cataracts and presbyopia. With its innovative Juvene IOL the company aims to bring to market this revolutionary device designed to restore full range of vision with high quality optics and improved safety […]
ECS07 DEVELOPMENT OF A NOVEL GORE SYNTHETIC CORNEA DEVICE A. Singh1,* 1W. L. Gore & Associates, Elkton, United States W.L. Gore & Associates is a material science company and a leading developer of successful medical devices with applications in cardiovascular and general surgery. Through our unique material technologies, we provide differentiated solutions to clinically critical unmet […]
ECS02 HOW DO I SEE AFTER A REFRACTIVE LENS EXCHANGE? – EXPERIENCE YOUR FUTURE IOL VISION PRIOR TO IMPLANTATION O. La Schiazza1,* 1DEZIMAL GmbH, Vienna, Austria DEZIMAL GmbH is an innovative start-up with cutting edge solutions in presbyopia treatment. DEZIMAL emerged from a cooperation between ACMIT Gmbh, an Austrian research and development center specialized in […]
